Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

May 2017

Reminder: CVS Specialty is New Preferred Specialty Pharmacy

As we announced in last month’s issue of Network Matters, Harvard Pilgrim has selected CVS Specialty as our preferred specialty pharmacy, effective July 1, 2017. 

CVS Specialty will provide specialty medications and additional education for your Harvard Pilgrim patients, and will collaborate with you on the close monitoring of their clinical response. They will also manage benefit investigations, determine plan coverage, and communicate financial obligations to the patient.

CVS Specialty will provide these services for all the medications noted in our Specialty Pharmacy Drug List.

Beginning on July 1, 2017, please contact CVS Specialty to order or renew any of these specialty medications for your Harvard Pilgrim patients. All previously approved prior authorizations will remain in effect for the originally approved time frames. You may submit an order for a specialty medication to CVS Specialty in one of the following ways:

  • Call toll-free at 800-237-2767 (from 7:30 a.m. to 9 p.m. ET)
  • E-prescribe by visiting CVS Specialty online at www.CVSspecialty.com
  • Fax your specialty prescriptions to 800-323-2445

If one or more of your Harvard Pilgrim patients is currently taking a specialty medication, you will receive a letter this month from Harvard Pilgrim and CVS Specialty with the relevant patient and drug information. These members will also receive letters informing them about our new partnership with CVS Specialty. 

If you have any further questions about this change, please contact the Provider Service Center at 800-708-4414.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


GIC Product Updates Effective July 1


Medical Drug Prior Authorization Program with CVS Health–NovoLogix

Reminder: CVS Specialty is New Preferred Specialty Pharmacy

Update to ExMI Therapy for Urinary Incontinence Medical Policy

Update to Infliximab Medical Review Criteria

Fecal Microbiota Transplantation Medical Policy Updated

Reducing Preventable Readmissions in the Medicare Advantage Population

Non-Medication Alternative Treatments for Chronic Pain

ACA Risk Adjustment Data Validation: Medical Chart Requests

Robust Discussion at Massachusetts Medical Directors’ Meeting


2017 Home Care Seasonal Flu Vaccine Fee Schedule


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator